St. Peter's Hospital

Nasal Spray VIRALEZE™ For Respiratory and Cold Viruses, Including New Strains

Retrieved on: 
Tuesday, September 19, 2023
Infection, Saint Peter, Travel, Leisure, COVID-19, Temperature, St. Peter's Hospital, Nose, Incidence, Work, Patient, Sport, Viral load, Hospital, Virus, Vaccine

VIRALEZE™ has shown the ability to trap and block a wide range and multiple strains of respiratory and cold viruses.

Key Points: 
  • VIRALEZE™ has shown the ability to trap and block a wide range and multiple strains of respiratory and cold viruses.
  • Key Features of VIRALEZE™ Barrier Nasal Spray:
    Barrier Formulation: VIRALEZE™ is specifically designed to target the nose where respiratory viruses first attach and multiply.
  • Broad-Spectrum: VIRALEZE™ traps and blocks a wide range of respiratory viruses, including common cold and flu viruses.
  • Its physical mechanism of action means it traps and blocks a broad spectrum of respiratory and cold viruses, including emerging viruses and strains.

Gary G. Singer, MD, FACP, FASN, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, September 28, 2021
Lazarus, Missouri Baptist Medical Center, Transplant, Continental, Human, Toronto School of communication theory, Alpha Omega Alpha, American Society of Transplantation, International Pediatric Nephrology Association, Chronic kidney disease, University, American Society of Nephrology, Founder, Medicine, Harvard Medical School, Research, Multimedia, Physician, Association, Washington University School of Medicine, International Society, Kidney, Choice, Barnes-Jewish Hospital, FASN, Partnership, National Kidney Foundation, Fellow, Health, Associate, Hypertension, Cancer, Internal medicine, Society, SSM Health, Hospital, Patient, Indonesian Choice Awards, MD, Loving Memory, American College, FACP, Select Medical, Renal Physicians Association, International Society of Nephrology, AMA, St. Peter's Hospital

With 34 years in the field of Nephrology, he is a respected consultant on topics of general nephrology, transplants, and dialysis.

Key Points: 
  • With 34 years in the field of Nephrology, he is a respected consultant on topics of general nephrology, transplants, and dialysis.
  • Dr. Singer is a Senior Partner with Midwest Nephrology Associates, where he specializes in chronic renal failure, dialysis, hypertension, and kidney and pancreas transplants.
  • He founded Midwest Nephrology Associates after five years as the Co-Director of the Renal Transplant Program at Washington University School of Medicine.
  • A respected voice in the Nephrology field, Dr. Singer has authored many articles in peer-reviewed journals, and co-authored several books.